HALEY MERTZ: Open Payments
NPI 1164931622 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,758 in 145 payments from 33 companies in 2025. Trend: 2023 $2,616 · 2024 $2,988 · 2025 $2,758
Food & beverage: $2,749Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $485 |
| UCB, Inc. | 18 | $376 |
| Lundbeck LLC | 10 | $175 |
| Amneal Pharmaceuticals LLC | 9 | $151 |
| Biogen, Inc. | 7 | $140 |
| ACADIA Pharmaceuticals Inc | 10 | $139 |
| Neurocrine BioSciences, Inc. | 5 | $122 |
| ARGENX US, INC. | 4 | $92 |
| CATALYST PHARMACEUTICALS, INC. | 4 | $82 |
| Eisai Inc. | 4 | $77 |
Products named: QULIPTA, VYEPTI, CREXONT, NUPLAZID, INGREZZA, TYSABRI, BOTOX, Briviact.
Industry payments across GA — which companies pay providers there.
